With private asset ETFs still awaiting regulatory approval, opportunistic issuers are continuing to crank out products that ...
Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the program to discuss two recent reports exploring the impacts of private equity on the US health care system.
Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...
Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...
Record revenues from management fees and a brighter outlook for M&A in the year ahead helped private equity's Big Four close 2024 on a high note.
Wall Street is often blamed for reducing corporate managers’ understanding of business to a single, gameable measure of ...